Bio Essence Corp (BIOE) Executive Compensation
Bio Essence Corp (BIOE) is a publicly traded company on the OTC, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: BIOE
CIK: 1723059
Exchange: OTC
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: CA
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Simon & Edward, LLP
Auditor SinceSince 12/31/2024 12:00:00 AM
Lead Engagement PartnerSundra Zhao
Audit LocationRowland Heights, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4/A | 2026-10-14 | 2024-10-28 | 4/A Filing | 0001213900-26-109431 | View SEC Doc Filr Page |
| 144 | 2026-10-13 | — | 144 Filing | 0001213900-26-108646 | View SEC Doc Filr Page |
| 10-Q | 2026-08-14 | 2026-06-30 | QUARTERLY REPORT | 0001213900-26-090174 | View SEC Doc Filr Page |
| 8-K/A | 2026-05-19 | 2026-04-24 | AMENDMENT NO. 1 TO FORM 8-K | 0001213900-26-058985 | View SEC Doc Filr Page |
| 10-Q | 2026-05-15 | 2026-03-31 | QUARTERLY REPORT | 0001213900-26-057529 | View SEC Doc Filr Page |
| 8-K | 2026-04-24 | 2026-04-24 | CURRENT REPORT | 0001213900-26-047207 | View SEC Doc Filr Page |
| 10-K | 2026-03-27 | 2025-12-31 | ANNUAL REPORT | 0001213900-26-035467 | View SEC Doc Filr Page |
| QUALIF | 2026-01-05 | — | QUALIF Filing | 9999999994-26-000004 | View SEC Doc Filr Page |
| 10-Q | 2025-11-12 | 2025-09-30 | QUARTERLY REPORT | 0001213900-25-108357 | View SEC Doc Filr Page |
| 1-A | 2025-10-17 | — | 1-A Filing | 0001213900-25-100050 | View SEC Doc Filr Page |
| 10-Q | 2025-08-14 | 2025-06-30 | QUARTERLY REPORT | 0001213900-25-076353 | View SEC Doc Filr Page |
| 10-Q | 2025-05-15 | 2025-03-31 | QUARTERLY REPORT | 0001213900-25-043524 | View SEC Doc Filr Page |
| 10-K | 2025-03-28 | 2024-12-31 | ANNUAL REPORT | 0001013762-25-003850 | View SEC Doc Filr Page |
| UPLOAD | 2024-12-05 | — | UPLOAD Filing | 0000000000-24-013393 | View SEC Doc Filr Page |
| 10-Q/A | 2024-11-27 | 2024-06-30 | AMENDMENT NO. 3 TO FORM 10-Q | 0001213900-24-103410 | View SEC Doc Filr Page |
| 10-Q/A | 2024-11-27 | 2024-03-31 | AMENDMENT NO. 3 TO FORM 10-Q | 0001213900-24-103408 | View SEC Doc Filr Page |
| 4 | 2024-11-18 | 2024-10-28 | 4 Filing | 0001213900-24-099693 | View SEC Doc Filr Page |
| 10-Q | 2024-11-14 | 2024-09-30 | QUARTERLY REPORT | 0001213900-24-098180 | View SEC Doc Filr Page |
| UPLOAD | 2024-11-08 | — | UPLOAD Filing | 0000000000-24-012471 | View SEC Doc Filr Page |
| 10-Q/A | 2024-10-30 | 2024-06-30 | AMENDMENT NO. 2 TO FORM 10-Q | 0001213900-24-091885 | View SEC Doc Filr Page |
| 10-Q/A | 2024-10-30 | 2024-03-31 | AMENDMENT NO. 2 TO FORM 10-Q | 0001213900-24-091884 | View SEC Doc Filr Page |
| UPLOAD | 2024-10-21 | — | UPLOAD Filing | 0000000000-24-011777 | View SEC Doc Filr Page |
| 4/A | 2024-10-11 | 2023-06-06 | 4/A Filing | 0001213900-24-087183 | View SEC Doc Filr Page |
| 4 | 2024-10-10 | 2024-07-11 | 4 Filing | 0001213900-24-087036 | View SEC Doc Filr Page |
| 4/A | 2024-10-10 | 2024-07-02 | 4/A Filing | 0001213900-24-086923 | View SEC Doc Filr Page |